<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(3)</volume><submitter>Abayomi SN</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The Mini-Cog is a rapid screening tool that can be administered to older adults to detect cognitive impairment (CI); however, the accuracy of the Mini-Cog to detect CI for older patients in various healthcare settings is unclear.&lt;h4>Objectives&lt;/h4>To evaluate the diagnostic accuracy of the Mini-Cog to screen for cognitive impairment in older patients across different healthcare settings.&lt;h4>Methods/design&lt;/h4>We searched nine electronic databases (including MEDLINE, Embase) from inception to January 2023. We included studies with patients ≥60 years old undergoing screening for cognitive impairment using the Mini-Cog across all healthcare settings. A cut-off of ≤ 2/5 was used to classify dementia, mild cognitive impairment (MCI), and cognitive impairment (defined as either MCI or dementia) across various settings. The diagnostic accuracy of the Mini-Cog was assessed against gold standard references such as the Diagnostic and Statistical Manual of Mental Disorders (DSM). A bivariate random-effects model was used to estimate accuracy and diagnostic ability. The risk of bias was assessed using QUADAS-2 criteria.&lt;h4>Results&lt;/h4>The systematic search resulted in 4,265 articles and 14 studies were included for analysis. To detect dementia (six studies, n = 4772), the Mini-Cog showed 76% sensitivity and 83% specificity. To detect MCI (two studies, n = 270), it showed 84% sensitivity and 79% specificity. To detect CI (eight studies, n = 2152), it had 67% sensitivity and 83% specificity. In the primary care setting, to detect either MCI, dementia, or CI (eight studies, n = 5620), the Mini-Cog demonstrated 73% sensitivity and 84% specificity. Within the secondary care setting (seven studies, n = 1499), the Mini-Cog to detect MCI, dementia or CI demonstrated 73% sensitivity and 76% specificity. A high or unclear risk of bias persisted in the patient selection and timing domain.&lt;h4>Conclusions&lt;/h4>The Mini-Cog is a quick and freely available screening tool and has high sensitivity and specificity to screen for CI in older adults across various healthcare settings. It is a practical screening tool for use in time-sensitive and resource-limited healthcare settings.</pubmed_abstract><journal>PloS one</journal><pagination>e0298686</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10939258</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The diagnostic accuracy of the Mini-Cog screening tool for the detection of cognitive impairment-A systematic review and meta-analysis.</pubmed_title><pmcid>PMC10939258</pmcid><pubmed_authors>Alhamdah Y</pubmed_authors><pubmed_authors>Chung F</pubmed_authors><pubmed_authors>He D</pubmed_authors><pubmed_authors>Yan E</pubmed_authors><pubmed_authors>Sritharan P</pubmed_authors><pubmed_authors>Tartaglia MC</pubmed_authors><pubmed_authors>Englesakis M</pubmed_authors><pubmed_authors>Saripella A</pubmed_authors><pubmed_authors>Abayomi SN</pubmed_authors></additional><is_claimable>false</is_claimable><name>The diagnostic accuracy of the Mini-Cog screening tool for the detection of cognitive impairment-A systematic review and meta-analysis.</name><description>&lt;h4>Background&lt;/h4>The Mini-Cog is a rapid screening tool that can be administered to older adults to detect cognitive impairment (CI); however, the accuracy of the Mini-Cog to detect CI for older patients in various healthcare settings is unclear.&lt;h4>Objectives&lt;/h4>To evaluate the diagnostic accuracy of the Mini-Cog to screen for cognitive impairment in older patients across different healthcare settings.&lt;h4>Methods/design&lt;/h4>We searched nine electronic databases (including MEDLINE, Embase) from inception to January 2023. We included studies with patients ≥60 years old undergoing screening for cognitive impairment using the Mini-Cog across all healthcare settings. A cut-off of ≤ 2/5 was used to classify dementia, mild cognitive impairment (MCI), and cognitive impairment (defined as either MCI or dementia) across various settings. The diagnostic accuracy of the Mini-Cog was assessed against gold standard references such as the Diagnostic and Statistical Manual of Mental Disorders (DSM). A bivariate random-effects model was used to estimate accuracy and diagnostic ability. The risk of bias was assessed using QUADAS-2 criteria.&lt;h4>Results&lt;/h4>The systematic search resulted in 4,265 articles and 14 studies were included for analysis. To detect dementia (six studies, n = 4772), the Mini-Cog showed 76% sensitivity and 83% specificity. To detect MCI (two studies, n = 270), it showed 84% sensitivity and 79% specificity. To detect CI (eight studies, n = 2152), it had 67% sensitivity and 83% specificity. In the primary care setting, to detect either MCI, dementia, or CI (eight studies, n = 5620), the Mini-Cog demonstrated 73% sensitivity and 84% specificity. Within the secondary care setting (seven studies, n = 1499), the Mini-Cog to detect MCI, dementia or CI demonstrated 73% sensitivity and 76% specificity. A high or unclear risk of bias persisted in the patient selection and timing domain.&lt;h4>Conclusions&lt;/h4>The Mini-Cog is a quick and freely available screening tool and has high sensitivity and specificity to screen for CI in older adults across various healthcare settings. It is a practical screening tool for use in time-sensitive and resource-limited healthcare settings.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-06-27T03:07:19.92Z</modification><creation>2026-06-27T03:05:38.293Z</creation></dates><accession>S-EPMC10939258</accession><cross_references><pubmed>38483857</pubmed><doi>10.1371/journal.pone.0298686</doi></cross_references></HashMap>